Estithmar Holding Taps Rothschild for Apex Health IPO in Doha

Estithmar Holding QPSC has appointed Rothschild & Co to serve as an advisor for the planned listing of its subsidiary, Apex Health, in Doha. The move initiates the process for Apex Health to potentially debut on the Qatar stock exchange, marking a significant step for the healthcare provider. Rothschild & Co, a global financial advisory firm, will provide strategic guidance throughout the initial public offering preparations for the healthcare entity, ensuring a structured approach to its market entry. This advisory role is key for navigating the complexities of a public listing.

Apex Health Financial Performance

Apex Health, a subsidiary of Estithmar Holding QPSC, reported significant financial performance in the coming years. The healthcare entity is projected to have generated 592 million riyals ($162 million) in profit during 2025. This strong financial outlook precedes Apex Health's planned initial public offering (IPO) in Doha, for which Rothschild & Co has been appointed as an advisor. The reported profit figure provides valuable insight into the company's fiscal health and operational strength as it prepares for its potential debut on the Qatar stock exchange. Such financial transparency is a key component in attracting potential investors to the upcoming listing.

Market Context and Significance

The potential initial public offering (IPO) of Apex Health could represent a rare listing on one of the Middle East’s quieter exchanges. Qatar's bourse has historically seen fewer major listings compared to some other more active markets in the Gulf region, making this development particularly noteworthy. The move by Estithmar Holding QPSC to list its healthcare subsidiary, Apex Health, signals a potential revitalization of IPO activity in Doha. This development follows the appointment of Rothschild & Co to advise on the listing process, indicating the company's intention to navigate the complexities of a public market debut and potentially set a precedent for future listings. This strategic decision notes a commitment to leveraging public markets for growth and capital generation.

The listing could attract renewed investor interest to the Qatar stock exchange, which has historically been less active in terms of new share offerings compared to markets in Saudi Arabia and the United Arab Emirates. A successful IPO for Apex Health would provide a significant boost to the local market, potentially encouraging other companies to consider similar strategies for capital generation and expansion. The strategic advisory role undertaken by Rothschild & Co shows the detailed preparation involved in bringing a company to public listing in this market environment, emphasizing the importance of expert guidance in such a significant financial undertaking. This potential listing is poised to be a key event in Qatar's financial landscape.

Key Players and Deal Structure

Estithmar Holding QPSC is pursuing the initial public offering (IPO) of its healthcare subsidiary, Apex Health, with Rothschild & Co advising on the transaction. The strategic move aims to list Apex Health on the Qatar stock exchange in Doha, enhancing its market visibility and access to capital. This collaboration brings together Estithmar Holding QPSC, a prominent entity in Qatar's business landscape, with Rothschild & Co, a global financial advisory firm headquartered in Paris with a long-standing reputation for expertise in capital markets. The advisory role of Rothschild & Co encompasses guiding Apex Health through the intricacies of its market debut, from regulatory compliance to investor relations. Key figures involved in the broader context of Rothschild & Co’s operations include Laura Gardner Cuesta and Omar El Chmouri, while Estithmar Holding QPSC is associated with figures such as Ramez Al-Khayyat and Moataz Al-Khayyat. The engagement shows a structured approach to bringing Apex Health to the public market, aiming for a successful and impactful listing.